[1]
Kumar, B.J., Mahalingam, V.T. and Kumar, G. 2024. CYP2C19 polymorphisms on escitalopram treatment outcome in South Indian population with major depressive disorder. ScienceRise: Pharmaceutical Science. 3 (49) (Jun. 2024), 70–77. DOI:https://doi.org/10.15587/2519-4852.2024.307289.